These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 16818651)

  • 1. HDJ-2 as a target for radiosensitization of glioblastoma multiforme cells by the farnesyltransferase inhibitor R115777 and the role of the p53/p21 pathway.
    Wang CC; Liao YP; Mischel PS; Iwamoto KS; Cacalano NA; McBride WH
    Cancer Res; 2006 Jul; 66(13):6756-62. PubMed ID: 16818651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Farnesyltransferase inhibitor, R115777, reverses the resistance of human glioma cell lines to ionizing radiation.
    Delmas C; Heliez C; Cohen-Jonathan E; End D; Bonnet J; Favre G; Toulas C
    Int J Cancer; 2002 Jul; 100(1):43-8. PubMed ID: 12115585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of the farnesyltransferase inhibitor R115777 in a rat mammary tumor model: role of Ha-ras mutations and use of microarray analysis in identifying potential targets.
    Yao R; Wang Y; Lu Y; Lemon WJ; End DW; Grubbs CJ; Lubet RA; You M
    Carcinogenesis; 2006 Jul; 27(7):1420-31. PubMed ID: 16403772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The farnesyltransferase inhibitor R115777 reduces hypoxia and matrix metalloproteinase 2 expression in human glioma xenograft.
    Delmas C; End D; Rochaix P; Favre G; Toulas C; Cohen-Jonathan E
    Clin Cancer Res; 2003 Dec; 9(16 Pt 1):6062-8. PubMed ID: 14676133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenylbutyrate sensitizes human glioblastoma cells lacking wild-type p53 function to ionizing radiation.
    Lopez CA; Feng FY; Herman JM; Nyati MK; Lawrence TS; Ljungman M
    Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):214-20. PubMed ID: 17707275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a R115777-resistant human multiple myeloma cell line with cross-resistance to PS-341.
    Buzzeo R; Enkemann S; Nimmanapalli R; Alsina M; Lichtenheld MG; Dalton WS; Beaupre DM
    Clin Cancer Res; 2005 Aug; 11(16):6057-64. PubMed ID: 16115951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Farnesyltransferase inhibitor (L-744,832) restores TGF-beta type II receptor expression and enhances radiation sensitivity in K-ras mutant pancreatic cancer cell line MIA PaCa-2.
    Alcock RA; Dey S; Chendil D; Inayat MS; Mohiuddin M; Hartman G; Chatfield LK; Gallicchio VS; Ahmed MM
    Oncogene; 2002 Nov; 21(51):7883-90. PubMed ID: 12420225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II and pharmacodynamic study of the farnesyltransferase inhibitor R115777 as initial therapy in patients with metastatic pancreatic adenocarcinoma.
    Cohen SJ; Ho L; Ranganathan S; Abbruzzese JL; Alpaugh RK; Beard M; Lewis NL; McLaughlin S; Rogatko A; Perez-Ruixo JJ; Thistle AM; Verhaeghe T; Wang H; Weiner LM; Wright JJ; Hudes GR; Meropol NJ
    J Clin Oncol; 2003 Apr; 21(7):1301-6. PubMed ID: 12663718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II study of the farnesyltransferase inhibitor R115777 in advanced melanoma (CALGB 500104).
    Gajewski TF; Salama AK; Niedzwiecki D; Johnson J; Linette G; Bucher C; Blaskovich MA; Sebti SM; Haluska F;
    J Transl Med; 2012 Dec; 10():246. PubMed ID: 23228035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Farnesyltransferase Inhibitor R115777 on Mitochondria of Plasmodium falciparum.
    Ha YR; Hwang BG; Hong Y; Yang HW; Lee SJ
    Korean J Parasitol; 2015 Aug; 53(4):421-30. PubMed ID: 26323840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarkers of anticancer activity of R115777 (Tipifarnib, Zarnestra) in human breast cancer models in vitro.
    Izbicka E; Campos D; Carrizales G; Patnaik A
    Anticancer Res; 2005; 25(5):3215-23. PubMed ID: 16101130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of potential markers of farnesyltransferase inhibition.
    Adjei AA; Davis JN; Erlichman C; Svingen PA; Kaufmann SH
    Clin Cancer Res; 2000 Jun; 6(6):2318-25. PubMed ID: 10873082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The farnesyltransferase inhibitor R115777 up-regulates the expression of death receptor 5 and enhances TRAIL-induced apoptosis in human lung cancer cells.
    Qiu Y; Liu X; Zou W; Yue P; Lonial S; Khuri FR; Sun SY
    Cancer Res; 2007 May; 67(10):4973-80. PubMed ID: 17510428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low dose of wortmannin reduces radiosensitivity of human glioblastoma cells through the p53 pathway.
    Okaichi K; Suzuki K; Morita N; Ikeda M; Takahashi H; Matsuda N; Watanabe M; Okumura Y
    Oncol Rep; 2002; 9(4):859-62. PubMed ID: 12066222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Farnesyltransferase inhibitor R115777 in myelodysplastic syndrome: clinical and biologic activities in the phase 1 setting.
    Kurzrock R; Kantarjian HM; Cortes JE; Singhania N; Thomas DA; Wilson EF; Wright JJ; Freireich EJ; Talpaz M; Sebti SM
    Blood; 2003 Dec; 102(13):4527-34. PubMed ID: 12947010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular response of human glioblastoma multiforme cells to ionizing radiation: cell cycle arrest, modulation of the expression of cyclin-dependent kinase inhibitors, and autophagy.
    Yao KC; Komata T; Kondo Y; Kanzawa T; Kondo S; Germano IM
    J Neurosurg; 2003 Feb; 98(2):378-84. PubMed ID: 12593626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transglutaminase 2 Inhibitor KCC009 Induces p53-Independent Radiosensitization in Lung Adenocarcinoma Cells.
    Huaying S; Dong Y; Chihong Z; Xiaoqian Q; Danying W; Jianguo F
    Med Sci Monit; 2016 Dec; 22():5041-5048. PubMed ID: 28002389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RhoB controls the 24 kDa FGF-2-induced radioresistance in HeLa cells by preventing post-mitotic cell death.
    Ader I; Toulas C; Dalenc F; Delmas C; Bonnet J; Cohen-Jonathan E; Favre G
    Oncogene; 2002 Sep; 21(39):5998-6006. PubMed ID: 12203112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The farnesyltransferase inhibitor R115777 (tipifarnib) in combination with tamoxifen acts synergistically to inhibit MCF-7 breast cancer cell proliferation and cell cycle progression in vitro and in vivo.
    Martin LA; Head JE; Pancholi S; Salter J; Quinn E; Detre S; Kaye S; Howes A; Dowsett M; Johnston SR
    Mol Cancer Ther; 2007 Sep; 6(9):2458-67. PubMed ID: 17876043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic Effects of Arsenite on Radiosensitization of Glioblastoma Cells.
    Ninomiya Y; Yu D; Sekine-Suzuki E; Nakajima T
    Anticancer Res; 2017 Aug; 37(8):4111-4117. PubMed ID: 28739695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.